You cannot register for this webinar

10:00 - 11:00 am CET Welcoming words and introduction - 3' Prof. Dr. Constance Katelaris Western Sydney University & Campbelltown Hospital, Sydney, Australia TALK 1 | The current HAE treatment landscape: how and where does gene editing of (pre)kallikrein fit? Prof. Dr. Marc Riedi University of California, San Diego, California, USA Talk: 15 minutes Discussion: 3 minutes TALK 2 | CRISPR technology: what is it and how does it work? Prof. Dr. Danny Cohn Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands Talk: 15 minutes Discussion: 3 minutes TALK 3 | Results from the clinical trials in HAE using CRISPR technology so far and the current status Hon. Associate Professor Dr Hilary Longhurst University of Auckland and Department of Immunology, Auckland City Hospital, New Zealand Talk: 15 minutes Discussion: 3 minutes Closing remarks Prof. Dr. Constance Katelaris Western Sydney University & Campbelltown Hospital, Sydney, Australia